CANBRIDGE PHARM.DL-00001 (MF1) — Financial Flexibility Index
CANBRIDGE PHARM.DL-00001 (MF1) has a Financial Flexibility Index of -0.08x as of December 2025. Free cash flow of €-38.21 Million (operating CF €-38.21 Million minus capex €6.00K) represents 0% of total liabilities (€507.15 Million). Check CANBRIDGE PHARM.DL-00001 (MF1) tangible net worth to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CANBRIDGE PHARM.DL-00001 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for CANBRIDGE PHARM.DL-00001 across 5 annual periods. For the full cash flow conversion analysis, see CANBRIDGE PHARM.DL-00001 cash conversion from operations.
Annual Financial Flexibility Index for CANBRIDGE PHARM.DL-00001 (2021–2025)
Year-by-year free cash flow to debt coverage for CANBRIDGE PHARM.DL-00001. Explore MF1 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.08x | €-38.21 Million | €-38.21 Million | €507.15 Million | ▲ +63.6% |
| 2024 | -0.21x | €-122.29 Million | €-122.39 Million | €591.30 Million | ▲ +62.1% |
| 2023 | -0.55x | €-237.37 Million | €-278.23 Million | €435.15 Million | ▲ +12.8% |
| 2022 | -0.63x | €-246.19 Million | €-280.98 Million | €393.49 Million | ▲ +78.6% |
| 2021 | -2.92x | €-581.74 Million | €-587.07 Million | €199.13 Million | — |